Back to search

United States· US:84897-052_135af82c-ec68-4d72-a882-22e662c2f38a

Dimethyl Sulfoxide

A dimethyl sulfoxide product containing dimethyl sulfoxide, registered in United States by Renova Pharmaceuticals LLC. The same ATC class is registered in 4 of our 19 countries.

ATC G04BX13

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDimethyl SulfoxideATCG04BX13REGISTER NO.US:84897-052_135af82c…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Dimethyl sulfoxide is registered in 4 of 19 countries.

Countries holding a registration under ATC G04BX13 (dimethyl sulfoxide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose

Dimethyl sulfoxide · ATC G04BX13

4 / 19 countries

  • Canada
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIMETHYL SULFOXIDE
Manufacturer
Renova Pharmaceuticals LLC
Country
United States (US)
ATC code
G04BX13
ATC class
Dimethyl sulfoxide
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    84897-052-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dimethyl sulfoxide in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dimethyl sulfoxide products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Latvia · Osteogēls

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/80d296b4-39c6-4590-98ed-d4f83ba67a70
GET /v1/drugs/80d296b4-39c6-4590-98ed-d4f83ba67a70?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVESICAL",
  "source": "ndc",
  "strength": ".54",
  "substance": "DIMETHYL SULFOXIDE",
  "productndc": "84897-052",
  "dosage_form": "IRRIGANT",
  "dea_schedule": null,
  "strength_unit": "g/mL",
  "application_number": "ANDA220173",
  "marketing_category": "ANDA"
}

See everything about dimethyl sulfoxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.